Technology | September 22, 2009

Toshiba Introduces Low-Contrast, CT-Like Vascular Imaging


September 22, 2009 – Toshiba America Medical Systems Inc. yesterday introduced Low-Contrast Imaging (LCI) for Toshiba’s Infinix-i systems with mid (12” x 12”) and large (12” x 16”) flat-panel detectors (FPD).

Toshiba will demonstrate its low-contrast imaging capabilities at this year’s Transcatheter Cardiovascular Therapeutics (TCT) annual meeting in San Francisco, Sept. 21-25, at its booth 705.

The company said it enables better visualization of soft tissue to improve the imaging and treatment of patients by offering CT-like images of soft tissue, including brain tissue, cerebral ventricles and hepatic visualization, without requiring additional exams.

Beneficial for both physicians and patients, low-contrast imaging allows better visualization of soft tissue in the angiography suite and enables more accurate diagnosis of a variety of diseases using a single system. Additionally, this technology may be used to confirm appropriate endpoints during interventional procedures, such as aortic stent-grafting. Capturing CT-like images without the use of an additional test helps improve accuracy and workflow in the angio suite. It also leads to lowering overall health care costs by using a single system to treat numerous diseases and handle multiple procedures.

The Infinix-i line features a five-axis C-arm that enables head-to-toe and fingertip-to-fingertip coverage and allows greater clinician access to the patient for diagnostic and interventional procedures. The freely moving components, ergonomically friendly design and five-axis positioner enable physicians to obtain optimal angles for cardiac diagnosis and interventional procedures without repositioning the patient. Infinix’s unique, flexible design improves workflow and collaboration between cardiologists, interventional cardiologists, anesthesiologists and clinical staff during exams, especially in hybrid OR settings.

For more information: www.medical.toshiba.com


Related Content

News | Cardiac Imaging

March 18, 2026 — Circle Cardiovascular Imaging (Circle CVI) has announced the expansion of its cvi42 cardiovascular ...

Home March 20, 2026
Home
News | Cardiac Imaging

March 19, 2026 — Heart disease is the leading cause of adult death worldwide, making cardiovascular disease diagnosis ...

Home March 20, 2026
Home
News | Cardiac Imaging

March 16, 2026 — The American Society for Preventive Cardiology (ASPC) will host its 2026 Virtual Imaging Symposium, a ...

Home March 17, 2026
Home
Feature | Cardiac Imaging

Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...

Home March 13, 2026
Home
News | Cardiac Imaging

March 6, 2026 — Building on its leadership in cardiac MR, Philips has received FDA 510(k) clearance for SmartHeart, an ...

Home March 09, 2026
Home
News | Cardiac Imaging

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...

Home February 26, 2026
Home
News | Cardiac Imaging

Feb. 13, 2026 — Conavi Medical Corp. recently highlighted the publication of new peer-reviewed research titled “Deep ...

Home February 16, 2026
Home
News | Cardiac Imaging

Jan. 27. 2026 — Circle Cardiovascular Imaging Inc. has announced the release of cvi42 v6.4, the latest version of its ...

Home January 28, 2026
Home
News | Cardiac Imaging

Jan. 6, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced FDA clearance to expand its ...

Home January 16, 2026
Home
News | Cardiac Imaging

Jan. 12, 2026 — YorLabs, Inc., a medical technology company providing next-generation intracardiac imaging solutions for ...

Home January 13, 2026
Home
Subscribe Now